Eqvista Blog

Founders’ guides to equity, valuations, and company growth.

Biotech Startup Ownership and Option Pool Trends in 2026

How much of a biotech startup do the founders end up with after a number of funding rounds? It’s not simply a matter of how much money you’ve raised. Investor ownership, employee stock options, top ups to the option pool and convertible securities all play a part in how the equity is split as you …

Read more

Anthropic IPO: What Eqvista Real-Time Company Valuation® Estimates Before ANT Hits Nasdaq

The AI boom has created some of the most valuable private companies in the world. Convincing the world of AI’s transformative potential is easy; justifying its sky-high valuations in public markets is another story.  Anthropic, the company behind Claude, is reportedly targeting a staggering $1.5 trillion to $2 trillion IPO valuation as it prepares for …

Read more

Top Shark Tank Deals of All Time

Bombas pitched for $200,000 and now reports $1.3 billion in lifetime sales. ZipZ Wine landed the biggest check in the show’s history, $2.5 million, and the company later faded from the market. The gap between those two outcomes shows what a Shark Tank deal really is: a pricing decision that changes who owns the company. …

Read more

How myTU Uses Eqvista Real-Time Company Valuation® to Navigate Series B Fundraising and Manage Dilution

As myTU prepared for its Series B, the fintech company needed more than a valuation based on its previous funding round. With Eqvista Real-Time Company Valuation®, myTU gained an independent, continuously updated market benchmark to support investor discussions, evaluate financing options, and make more informed decisions about equity dilution. myTU is a growing fintech company …

Read more

Top Investments by Accel in 2026

Which were the biggest rounds Accel backed in 2026, and what can founders learn from them? The largest were in AI, defense and security companies that were already growing fast. Anthropic’s $30 billion Series G was the biggest by far. But the rounds Accel led, such as Legora, Armadin, Basis and Fractile, show more about …

Read more

Acid Test /Quick Ratio by Industry 2026

Imagine two companies. For every $1 of short-term bills, a biotech firm holds $5.13 in cash and quick assets. A discount store holds just 32 cents. Why such a big gap? The answer is how each business earns money. Biotech firms sit on cash raised from investors, while discount stores collect cash at the register …

Read more

What Are Common Equity Grant Sizes for Non-AI Roles Now?

AI’s dominance in venture capital has been nothing short of remarkable. In Q1 2023, AI accounted for 21.05% of global VC funding. By Q1 2026, that figure had surged to 80.61%, meaning that for every dollar deployed by venture capitalists globally, roughly 80 cents is flowing into AI. It stands to reason that, if capital …

Read more

ROE by Sector 2026: Which Industries Generate the Highest Returns?

A 12% ROE beats the 9.4% earned by restaurants, but trails the 14.1% earned in engineering and construction. Same number, two different verdicts. This guide uses October 2026 data on 128 U.S. industries to show which sectors earn the most on shareholder equity, which earn the least, and how to benchmark your own company against …

Read more

From AI Risk to a $20M Seed Round: The NeuralTrust Story

A wrong answer from an AI chatbot is one thing. An AI agent leaking internal information or bypassing security controls is another. That distinction led Joan Vendrell, co-founder and CEO of NeuralTrust, to build a platform that helps enterprises monitor, secure, and govern AI agents connected to their business systems. Drawing on his experience at …

Read more

Top Mergers and Acquisitions Deals in the US in 2026

US companies spent more money on deals in 2026 than in any recent year on record. The numbers are striking: SpaceX bought xAI at a combined valuation of $1.25 trillion, two of the largest apartment landlords in the country merged into one company, and a handful of pharmaceutical companies spent over $67 billion acquiring drug …

Read more

Eqvista Recognized Again as a 2026 Inc. Power Partner Award Winner

Eqvista has once again been named a 2026 Inc. Power Partner Award winner, recognizing our role in helping entrepreneurs and businesses grow. The annual Inc. Power Partner Awards honor leading B2B companies with a strong track record of supporting businesses through the challenges of building, operating, and scaling. This recognition reflects the trust our clients …

Read more

ESG in Private Equity: 2026 Data And Trends

Private equity has an ESG commitment problem, but not where you might think. PE firms are putting more money, teams, and targets behind ESG, yet those commitments are still struggling to reach the portfolio companies that have to deliver them. In 2026, the real question isn’t whether private equity takes ESG seriously. It’s whether those …

Read more

Eqvista Launches Company-Sponsored Tender Offers for Private Company Liquidity

Eqvista has launched Company-Sponsored Tender Offers, giving private companies a new way to organize shareholder liquidity events directly within their equity management platform. As companies stay private longer, employees and early investors often wait years for an opportunity to sell their shares. Eqvista’s new capabilities help companies organize these transactions while maintaining control over participation, …

Read more

How Liscio Moved From Carta to Eqvista in Two Days Without Losing Its Cap Table History

Liscio needed more than a new cap table platform. It needed a provider that could preserve its equity history, support an active company restructure, and stay involved beyond the migration. Liscio is a File Intelligence platform built specifically for accounting and tax professionals, helping firms manage documents, client requests, communication, and tax workflows while delivering …

Read more

Meet Jeff Yang: From Finance and Capital Markets to Valuation at Eqvista

Behind every company valuation is a combination of financial analysis, industry research, judgment, and an understanding of the business itself. At Eqvista, that work is carried out by valuation professionals who bring experience across different areas of finance and capital markets. In this employee spotlight, we speak with Jeff Yang, Senior Valuation Analyst at Eqvista, …

Read more

Over 25,000 companies use Eqvista to simplify equity, stay compliant, and scale—whether hiring their first employee or closing their next round.